A BetterLife Pharma @BetterLifeBio

BetterLife is an emerging biotech company focused on developing & commercializing patient-friendly compounds to treat mental health issues $BETR BETR | BETRF abetterlifepharma.com Joined January 2021

Tweets

820
Followers

283
Following

241
Likes

48

A BetterLife Pharma @BetterLifeBio

3 months ago

Most psychedelics carry a hidden risk - 5-HT2B agonism - 5-HT2B activation is a known liability for LSD, psilocybin, DMT and many non-hallucinogenic analogs. BETR-001 is a 5-HT2B antagonist - zero agonism. Full cardiac safety package completed in IND studies.

2 0 2 271 2

View Details

A BetterLife Pharma @BetterLifeBio

3 months ago

BETR-001 doesn’t just fix one problem - it hits the receptors involved in many of the conditions. Animal models of depression-anxiety: highly effective. Previous version already showed near-cure results in cluster "suicide" headache patients (Karst 2010).

0 0 1 53 0

View Details

A BetterLife Pharma @BetterLifeBio

3 months ago

BETR-001 changes everything. Previous version already safe in humans. New data proves it’s a powerful inducer of both short- and long-term neuroplasticity - without any psychedelic effects.

0 0 1 44 0

View Details

A BetterLife Pharma @BetterLifeBio

3 months ago

Psychedelics work because they drive new neuronal growth & connections. That’s why they help depression, anxiety, PTSD, addiction & pain. But the hallucinations have always been considered baggage.

0 0 1 31 0

View Details

A BetterLife Pharma @BetterLifeBio

4 months ago

The future of brain repair is here - and it doesn’t make you hallucinate. BetterLife has unlocked BETR-001 - a patented LSD derivative that is a potent neuroplastogen with ZERO hallucinations.

0 0 1 55 0

View Details

A BetterLife Pharma @BetterLifeBio

4 months ago

BB's Stock Haven : $BETRF 🧠BetterLife Pharma: Revol... investorshub.advfn.com/boards/read_ms… via @Investors_Hub

0 0 2 59 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

BetterLife Pharma achieves a significant milestone on its way to clinical trials! The US Patent and Trademark Office grants composition of matter for BETR-001 and its related derivatives. More can be read here - tinyurl.com/4m2v5jpx #PTSD #depression #anxiety #neuropathicpain

0 0 0 69 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001 globenewswire.com/NewsRoom/Relea…

0 0 2 59 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders globenewswire.com/NewsRoom/Relea…

0 0 0 52 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

BetterLife Announces Debt Settlements globenewswire.com/NewsRoom/Relea…

0 0 1 49 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

BetterLife Pharma Appoints Corporate Advisor globenewswire.com/NewsRoom/Relea…

0 0 0 41 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

BetterLife Pharma Appoints New Director globenewswire.com/NewsRoom/Relea…

0 0 0 31 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

💊 Drug Development In drug discovery, a wide range of pathways are pervasive. But the overriding consistency with all approaches is the hunger, drive, and need to address complexities & challenges of diseases. So, therapies and medicines need to offer tailored made solutions.

0 0 0 43 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

💊 Orphan Drug Designation Unlike regulatory hurdles, the orphan drug designation was enacted to tackle economic challenges faced by biotech working on rare diseases. The approach is centered on giving financial incentives to biopharma so they can bring a drug to the market.

0 0 1 43 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

💊 FDA’s accelerated approval pathway is a change agent. It can alleviate serious & life-threatening strains on society. However, a pathway concern is that it doesn't require a drug to demonstrate clinical benefit before being approved. Change is needed! tinyurl.com/3reny68p

0 0 1 35 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

💊 Accelerated Approval Designation An accelerated approval pathway tackles serious & life-threatening conditions. So, it's important for trials to be timely, safeguarded, & transparent. 2025, FDA indicates access to meaningful drugs is vital for patients with high unmet needs.

0 0 1 32 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

🌟Year of #Neuroscience? J&J off to a flying 2025 with $14.6B buy of Intra-Cellular Therapies. It's clear @JNJNews is beefing up its best-in-class neurological disorder treatments. A complement to its psychiatric disorder drug @Spravato_center. What else is in store in 2025?

0 0 2 145 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

💊 Fast Track Designation The @FDA approved 50 novel drugs in 2024 and @drughunter_com said 14% went through the ‘accelerated approval pathway’. Total number of novel drugs approved fell 10% 2023-2024. Shockingly 44% were granted Fast Track Designation. $BETR: CSE $BETRF: OTCQB

0 0 0 262 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

💊 Fast Track Designation The Biotech landscape is froth with the need for speed! The key for the FDA is balance patient safety, medicinal sustainability, & corporate suitability. Real aims are meeting serious conditions and high unmet needs. $BETR: CSE $BETRF: OTCQB

0 0 0 324 0

View Details

A BetterLife Pharma @BetterLifeBio

a year ago

💡Stress IS part of life. Managing, reducing its impact is important with clear guidance + support. Steps that can be taken & resources can be utilized. It doesn't need to be a solo journey or painful exercise. Teachings, tools, techniques are available. tinyurl.com/4hf3pmcc